Compendium of Cancer Genome Aberrations

Changes

DIG5:Volunteer Assignments and Opportunities (view source)

Revision as of 11:04, 29 January 2024

2,032 bytes added ,  11:04, 29 January 2024
no edit summary
Line 16: Line 16:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 +
|-
 +
|CHAPTER 2 (TUMOURS OF THE OESOPHAGUS)
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 
|-
 
|-
 
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
 
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
Line 115: Line 135:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 3 (TUMOURS OF THE STOMACH)
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 
|-
 
|-
 
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
 
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
Line 259: Line 299:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
+
|CHAPTER 4 (TUMOURS OF THE SMALL INTESTINE AND AMPULLA)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
+
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 281: Line 330:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
+
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 292: Line 341:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
+
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 303: Line 352:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
+
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 314: Line 363:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
+
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 325: Line 374:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
+
|CHAPTER 5 (TUMOURS OF THE APPENDIX)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
+
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
 
|Disease
 
|Disease
 
|
 
|
Line 347: Line 405:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
+
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 358: Line 416:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
+
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 369: Line 427:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
+
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 380: Line 438:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
+
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 391: Line 449:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
+
|CHAPTER 6 (TUMOURS OF THE COLON AND RECTUM)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
+
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
 
|Disease
 
|Disease
 
|
 
|
Line 413: Line 480:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
+
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 424: Line 491:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
+
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
 
|Disease
 
|Disease
 
|
 
|
Line 435: Line 502:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_condyloma|Anal condyloma]]
+
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 446: Line 513:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
+
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 457: Line 524:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
+
|CHAPTER 7 (TUMOURS OF THE ANAL CANAL)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
+
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
 
|Disease
 
|Disease
 
|
 
|
Line 479: Line 555:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
+
|[[DIG5:Anal_condyloma|Anal condyloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 490: Line 566:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
+
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
 
|Disease
 
|Disease
 
|
 
|
Line 501: Line 577:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
+
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 512: Line 588:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
+
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 523: Line 599:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
+
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 534: Line 610:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
+
|CHAPTER 8 (TUMOURS OF THE LIVER AND INTRAHEPATIC BILE DUCTS)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
+
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
 
|Disease
 
|Disease
 
|
 
|
Line 556: Line 641:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
+
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 567: Line 652:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
+
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 578: Line 663:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
+
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 589: Line 674:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
+
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 600: Line 685:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
+
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 611: Line 696:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
+
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
 
|Disease
 
|Disease
 
|
 
|
Line 622: Line 707:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
+
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 633: Line 718:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
+
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 644: Line 729:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
+
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 655: Line 740:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
+
|CHAPTER 9 (TUMOURS OF THE GALLBLADDER AND EXTRAHEPATIC BILE DUCTS)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
+
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
 
|Disease
 
|Disease
 
|
 
|
Line 677: Line 771:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
+
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 688: Line 782:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
+
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
 
|Disease
 
|Disease
 
|
 
|
Line 699: Line 793:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
+
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
 
|Disease
 
|Disease
 
|
 
|
Line 710: Line 804:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
+
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
 
|Disease
 
|Disease
 
|
 
|
Line 721: Line 815:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
+
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
 
|Disease
 
|Disease
 
|
 
|
Line 732: Line 826:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
+
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
 
|Disease
 
|Disease
 
|
 
|
Line 743: Line 837:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
+
|CHAPTER 10 (TUMOURS OF THE PANCREAS)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
+
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
 
|Disease
 
|Disease
 
|
 
|
Line 765: Line 868:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
+
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
 
|Disease
 
|Disease
 
|
 
|
Line 776: Line 879:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
+
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 787: Line 890:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
+
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 901:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
+
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 809: Line 912:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Insulinoma|Insulinoma]]
+
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 820: Line 923:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Gastrinoma|Gastrinoma]]
+
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 831: Line 934:  
|
 
|
 
|-
 
|-
−
|[[DIG5:VIPoma|VIPoma]]
+
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 842: Line 945:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Glucagonoma|Glucagonoma]]
+
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 853: Line 956:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Somatostatinoma|Somatostatinoma]]
+
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 864: Line 967:  
|
 
|
 
|-
 
|-
−
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
+
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
 
|Disease
 
|Disease
 
|
 
|
Line 875: Line 978:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
+
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 886: Line 989:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
+
|[[DIG5:Insulinoma|Insulinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 897: Line 1,000:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
+
|[[DIG5:Gastrinoma|Gastrinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 908: Line 1,011:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
+
|[[DIG5:VIPoma|VIPoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 919: Line 1,022:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
+
|[[DIG5:Glucagonoma|Glucagonoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 930: Line 1,033:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
+
|[[DIG5:Somatostatinoma|Somatostatinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 941: Line 1,044:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
+
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 952: Line 1,055:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
+
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 963: Line 1,066:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
+
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
−
|Disease
+
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (HAEMATOLYMPHOID TUMOURS OF THE DIGESTIVE SYSTEM)
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|-
 +
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 974: Line 1,218:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
+
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 985: Line 1,229:  
|
 
|
 
|-
 
|-
−
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
+
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 996: Line 1,240:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
+
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,007: Line 1,251:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
+
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,018: Line 1,262:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
+
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,029: Line 1,273:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
+
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,040: Line 1,284:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
+
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,051: Line 1,295:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
+
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,062: Line 1,306:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
+
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,073: Line 1,317:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
+
|CHAPTER 12 (MESENCHYMAL TUMOURS OF THE DIGESTIVE SYSTEM)
−
|Disease
+
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
+
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,095: Line 1,348:  
|
 
|
 
|-
 
|-
−
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
+
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
−
|Disease
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|-
  −
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
  −
|Disease
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|-
  −
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
  −
|Disease
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|-
  −
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
   
|Disease
 
|Disease
 
|
 
|
Line 1,402: Line 1,622:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 13 (OTHER TUMOURS OF THE DIGESTIVE SYSTEM)
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 
|-
 
|-
 
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
 
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14132"